NHSE has published details of the DSQS arrangements from August 1.
In a letter, NHSE states that the DSQS medication review requirement to include “at least 10 per cent of dispensing patients” has been reduced to a minimum of 7.5 per cent this year, in light of the current circumstances.
Practices are asked to prioritise patients who they consider to be higher-risk or would benefit most from a review. Practices will also be able to undertake these reviews remotely.
The letter also advises of protection payments to cover the period April 1-July 31, during which time the DSQS was suspended.
Commissioners are told to take a “supportive approach” to DSQS given the current circumstances. This includes taking a proportionate approach to the requirement for practices to partake in one clinical audit of dispensing services, and have due regard to the impact of COVID-19 on practices’ training plans.